AstraZeneca EBITDA Margin 2012-2025 | AZN

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for AstraZeneca (AZN) over the last 10 years. The current EBITDA margin for AstraZeneca as of September 30, 2025 is .

AstraZeneca EBITDA Margin Historical Data
Date	TTM Revenue	TTM EBITDA	EBITDA Margin
2025-09-30	$58.13B	$19.36B	33.31%
2025-06-30	$56.50B	$18.15B	32.13%
2025-03-31	$54.98B	$17.28B	31.43%
2024-12-31	$54.07B	$16.69B	30.87%
2024-09-30	$51.21B	$14.88B	29.06%
2024-06-30	$49.13B	$14.19B	28.88%
2024-03-31	$47.61B	$13.90B	29.19%
2023-12-31	$45.81B	$13.58B	29.64%
2023-09-30	$45.00B	$13.59B	30.21%
2023-06-30	$44.49B	$12.94B	29.08%
2023-03-31	$43.84B	$11.10B	25.32%
2022-12-31	$44.35B	$9.24B	20.83%
2022-09-30	$45.15B	$8.56B	18.96%
2022-06-30	$44.04B	$7.10B	16.12%
2022-03-31	$41.49B	$7.08B	17.07%
2021-12-31	$37.42B	$7.59B	20.27%
2021-09-30	$32.82B	$7.97B	24.29%
2021-06-30	$29.53B	$8.83B	29.90%
2021-03-31	$27.58B	$8.94B	32.42%
2020-12-31	$26.62B	$8.31B	31.22%
2020-09-30	$25.87B	$8.25B	31.88%
2020-06-30	$25.70B	$7.75B	30.15%
2020-03-31	$25.25B	$6.97B	27.62%
2019-12-31	$24.38B	$6.69B	27.42%
2019-09-30	$24.14B	$7.21B	29.85%
2019-06-30	$23.07B	$7.28B	31.56%
2019-03-31	$22.40B	$7.51B	33.51%
2018-12-31	$22.09B	$7.14B	32.32%
2018-09-30	$21.45B	$6.19B	28.88%
2018-06-30	$22.34B	$6.45B	28.86%
2018-03-31	$22.24B	$6.54B	29.42%
2017-12-31	$22.47B	$6.71B	29.88%
2017-09-30	$22.27B	$8.04B	36.11%
2017-06-30	$21.74B	$7.88B	36.24%
2017-03-31	$22.29B	$7.23B	32.42%
2016-12-31	$23.00B	$7.26B	31.56%
2016-09-30	$23.82B	$5.94B	24.94%
2016-06-30	$24.06B	$6.04B	25.11%
2016-03-31	$24.77B	$6.79B	27.42%
2015-12-31	$24.71B	$6.97B	28.19%
2015-09-30	$25.03B	$5.83B	23.31%
2015-06-30	$25.69B	$5.49B	21.35%
2015-03-31	$26.14B	$5.65B	21.62%
2014-12-31	$26.55B	$5.42B	20.41%
2014-09-30	$26.77B	$6.76B	25.26%
2014-06-30	$26.41B	$7.46B	28.26%
2014-03-31	$25.88B	$7.80B	30.12%
2013-12-31	$25.81B	$8.30B	32.14%
2013-09-30	$26.15B	$9.01B	34.45%
2013-06-30	$26.58B	$9.82B	36.93%
2013-03-31	$27.01B	$10.06B	37.23%
2012-12-31	$27.97B	$10.67B	38.13%
2012-09-30	$29.35B	$11.08B	37.74%
2012-06-30	$30.88B	$12.98B	42.03%
2012-03-31	$32.65B	$14.08B	43.12%
2011-12-31	$33.59B	$15.35B	45.68%
2011-09-30	$33.55B	$16.34B	48.71%
2011-06-30	$33.24B	$14.55B	43.77%
2011-03-31	$32.99B	$14.37B	43.57%
2010-12-31	$33.27B	$14.24B	42.79%
2010-09-30	$33.60B	$13.84B	41.19%
2010-06-30	$33.90B	$14.44B	42.59%
2010-03-31	$33.68B	$14.14B	41.98%
2009-12-31	$32.80B	$13.63B	41.55%
2009-09-30	$32.05B	$12.62B	39.37%
2009-06-30	$31.63B	$11.93B	37.72%
2009-03-31	$31.63B	$11.69B	36.95%
2008-12-31	$31.60B	$11.24B	35.57%
2008-09-30	$31.58B	$16.68B	52.83%
2008-06-30	$30.95B	$20.91B	67.57%
2008-03-31	$30.30B	$20.27B	66.90%
2007-12-31	$29.59B	$19.83B	67.03%
2007-09-30	$28.57B	$13.41B	46.93%
2007-06-30	$27.94B	$8.57B	30.68%
2007-03-31	$27.26B	$8.70B	31.90%
2006-12-31	$26.48B	$8.48B	32.02%
2006-09-30	$25.61B	$8.69B	33.93%
2006-06-30	$24.88B	$8.34B	33.51%
2006-03-31	$24.39B	$8.10B	33.20%
2005-12-31	$23.95B	$7.63B	31.88%
2005-09-30	$23.46B	$7.58B	32.30%
2005-06-30	$22.94B	$7.73B	33.71%
2005-03-31	$22.10B	$6.41B	29.01%
2004-12-31	$21.43B	$6.04B	28.18%
2004-09-30	$20.50B	$4.02B	19.59%
2004-06-30	$20.04B	$3.27B	16.34%
2004-03-31	$19.19B	$3.73B	19.44%
2003-12-31	$18.85B	$3.91B	20.75%
2003-09-30	$18.87B	$4.23B	22.43%
2003-06-30	$18.42B	$4.02B	21.84%
2003-03-31	$18.37B	$4.14B	22.52%
2002-12-31	$18.05B	$3.98B	22.02%
2002-09-30	$17.59B	$4.32B	24.54%
2002-06-30	$17.19B	$4.28B	24.92%
2002-03-31	$16.91B	$4.20B	24.86%
2001-12-31	$16.48B	$3.94B	23.92%
2001-09-30	$16.18B	$7.54B	46.58%
2001-06-30	$16.53B	$10.71B	64.77%
2001-03-31	$16.40B	$13.52B	82.41%
2000-12-31	$17.01B	$17.01B	100.00%
2000-06-30	$13.11B	$13.11B	100.00%
2000-03-31	$12.95B	$12.95B	100.00%
1998-12-31	$15.40B	$15.40B	100.00%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$299.372B	$54.073B
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.

Stock Name	Country	Market Cap	PE Ratio
Amgen (AMGN)	United States	$206.949B	17.59
Gilead Sciences (GILD)	United States	$189.204B	18.62
Bristol Myers Squibb (BMY)	United States	$126.196B	10.08
GSK (GSK)	United Kingdom	$122.773B	13.32
Vertex Pharmaceuticals (VRTX)	United States	$121.257B	31.22
Regeneron Pharmaceuticals (REGN)	United States	$82.557B	21.77
CSL (CSLLY)	Australia	$62.313B	0.00
Argenex SE (ARGX)	Netherlands	$50.215B	62.04
Alnylam Pharmaceuticals (ALNY)	United States	$43.354B	1426.78
Insmed (INSM)	United States	$31.961B	0.00
Biogen (BIIB)	United States	$29.514B	13.16
Royalty Pharma (RPRX)	United States	$25.774B	9.88
BioNTech SE (BNTX)	Germany	$24.009B	0.00
Incyte (INCY)	United States	$21.279B	20.37
Genmab (GMAB)	Denmark	$19.850B	14.93
Exact Sciences (EXAS)	United States	$19.688B	543.05
Revolution Medicines (RVMD)	United States	$18.847B	0.00
Illumina (ILMN)	United States	$18.293B	24.68
Roivant Sciences (ROIV)	United Kingdom	$17.958B	0.00
Moderna (MRNA)	United States	$16.024B	0.00
Sino Biopharmaceutical (SBMFF)	Hong Kong, SAR China	$14.594B	0.00
Ascendis Pharma (ASND)	Denmark	$13.768B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$13.465B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	21.26
Guardant Health (GH)	United States	$12.837B	0.00
Exelixis (EXEL)	United States	$11.770B	18.84
Avidity Biosciences (RNA)	United States	$11.281B	0.00
BioMarin Pharmaceutical (BMRN)	United States	$11.168B	20.25
QIAGEN (QGEN)	Netherlands	$10.759B	20.61
Bio-Techne Corp (TECH)	United States	$10.448B	37.94
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.057B	39.22
Halozyme Therapeutics (HALO)	United States	$9.552B	15.27
Abivax SA (ABVX)	France	$9.231B	0.00
Axsome Therapeutics (AXSM)	United States	$9.203B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$9.035B	42.17
Praxis Precision Medicines (PRAX)	United States	$8.052B	0.00
Repligen (RGEN)	United States	$8.003B	85.65
Bio-Rad Laboratories (BIO.B)	United States	$7.959B	28.62
Krystal Biotech (KRYS)	United States	$7.909B	40.89
Cytokinetics (CYTK)	United States	$7.622B	0.00
Nuvalent (NUVL)	United States	$7.532B	0.00
Vaxcyte (PCVX)	United States	$7.350B	0.00
Belite Bio (BLTE)	United States	$7.048B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.915B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
PTC Therapeutics (PTCT)	United States	$5.996B	8.14
ImmunityBio (IBRX)	United States	$5.959B	0.00
Alkermes (ALKS)	Ireland	$5.764B	16.95
Kymera Therapeutics (KYMR)	United States	$5.726B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.282B	136.27
Cogent Biosciences (COGT)	United States	$5.279B	0.00
Mirum Pharmaceuticals (MIRM)	United States	$5.164B	0.00
Celcuity (CELC)	United States	$4.939B	0.00
Scholar Rock Holding (SRRK)	United States	$4.858B	0.00
Immunovant (IMVT)	United States	$4.741B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$4.645B	0.00
TG Therapeutics (TGTX)	United States	$4.582B	10.38
Zealand Pharma (ZLDPF)	Denmark	$4.551B	4.61
Structure Therapeutics (GPCR)	United States	$4.546B	0.00
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Amicus Therapeutics (FOLD)	United States	$4.489B	357.50
Apogee Therapeutics (APGE)	United States	$4.252B	0.00
CG Oncology (CGON)	United States	$4.062B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$3.986B	33.66
Arcellx (ACLX)	United States	$3.934B	0.00
ADMA Biologics Inc (ADMA)	United States	$3.910B	27.85
GRAIL (GRAL)	United States	$3.901B	0.00
Erasca (ERAS)	United States	$3.805B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.748B	92.00
Liquidia (LQDA)	United States	$3.744B	0.00
Anbio Biotechnology (NNNN)	Germany	$3.691B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.402B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.346B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.266B	95.76
Viking Therapeutics (VKTX)	United States	$3.215B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.198B	0.00
Legend Biotech (LEGN)	United States	$3.158B	0.00
Denali Therapeutics (DNLI)	United States	$3.092B	0.00
Edgewise Therapeutics (EWTX)	United States	$3.081B	0.00
Twist Bioscience (TWST)	United States	$3.019B	0.00
Disc Medicine (IRON)	United States	$3.009B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.972B	75.77
IDEAYA Biosciences (IDYA)	United States	$2.820B	0.00
Viridian Therapeutics (VRDN)	United States	$2.792B	0.00
Vera Therapeutics (VERA)	United States	$2.781B	0.00
Immunome (IMNM)	United States	$2.745B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$2.743B	0.00
Alumis (ALMS)	United States	$2.734B	0.00
Spyre Therapeutics (SYRE)	United States	$2.725B	0.00
Beam Therapeutics (BEAM)	United States	$2.691B	0.00
Travere Therapeutics (TVTX)	United States	$2.658B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.648B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.409B	6.54
Adaptive Biotechnologies (ADPT)	United States	$2.408B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.405B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.383B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.356B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.288B	0.00
Arcus Biosciences (RCUS)	United States	$2.271B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.249B	0.00
Dianthus Therapeutics (DNTH)	United States	$2.194B	0.00
Maze Therapeutics (MAZE)	United States	$2.167B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.147B	11.72
Recursion Pharmaceuticals (RXRX)	United States	$2.069B	0.00
Mesoblast (MESO)	Australia	$2.058B	0.00
Zai Lab (ZLAB)	China	$2.015B	0.00
Nuvation Bio (NUVB)	United States	$1.954B	0.00
Sarepta Therapeutics (SRPT)	United States	$1.939B	0.00
Stoke Therapeutics (STOK)	United States	$1.851B	48.36
ANI Pharmaceuticals (ANIP)	United States	$1.839B	14.26
Vericel (VCEL)	United States	$1.830B	150.79
Syndax Pharmaceuticals (SNDX)	United States	$1.826B	0.00
Dynavax Technologies (DVAX)	United States	$1.820B	53.45
MannKind (MNKD)	United States	$1.775B	57.80
Olema Pharmaceuticals (OLMA)	United States	$1.741B	0.00
Nurix Therapeutics (NRIX)	United States	$1.733B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.714B	0.00
Zymeworks (ZYME)	United States	$1.700B	0.00
MBX Biosciences (MBX)	United States	$1.691B	0.00
Tango Therapeutics (TNGX)	United States	$1.685B	0.00
Tyra Biosciences (TYRA)	United States	$1.655B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.616B	0.00
Sionna Therapeutics (SION)	United States	$1.612B	0.00
Rapt Therapeutics (RAPT)	United States	$1.599B	0.00
UniQure (QURE)	Netherlands	$1.598B	0.00
Celldex Therapeutics (CLDX)	United States	$1.579B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.547B	0.00
Alvotech (ALVO)	Luxembourg	$1.544B	22.26
Precigen (PGEN)	United States	$1.518B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.492B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
NeoGenomics (NEO)	United States	$1.478B	0.00
Trevi Therapeutics (TRVI)	United States	$1.470B	0.00
Intellia Therapeutics (NTLA)	United States	$1.422B	0.00
Upstream Bio (UPB)	United States	$1.416B	0.00
AnaptysBio (ANAB)	United States	$1.377B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.369B	0.00
Fortrea Holdings (FTRE)	United States	$1.354B	28.73
Novavax (NVAX)	United States	$1.341B	3.41
Rapport Therapeutics (RAPP)	United States	$1.291B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.273B	61.09
Biohaven (BHVN)	United States	$1.228B	0.00
Kodiak Sciences (KOD)	United States	$1.222B	0.00
Inhibrx Biosciences (INBX)	United States	$1.220B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.186B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.172B	0.00
Immatics (IMTX)	Germany	$1.171B	0.00
Zenas BioPharma (ZBIO)	United States	$1.170B	0.00
Compass Therapeutics (CMPX)	United States	$1.160B	0.00
Certara (CERT)	United States	$1.152B	21.26
Septerna (SEPN)	United States	$1.138B	0.00
NovoCure (NVCR)	Jersey	$1.136B	0.00
Pharming Group (PHAR)	Netherlands	$1.129B	0.00
EyePoint (EYPT)	United States	$1.101B	0.00
Sana Biotechnology (SANA)	United States	$1.047B	0.00
Oric Pharmaceuticals (ORIC)	United States	$1.015B	0.00
Nanobiotix S.A - (NBTX)	France	$1.009B	0.00
Iovance Biotherapeutics (IOVA)	United States	$1.004B	0.00
Ventyx Biosciences (VTYX)	United States	$1.002B	0.00
Vir Biotechnology (VIR)	United States	$1.000B	0.00
Urogen Pharma (URGN)	United States	$0.999B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$0.996B	0.00
Geron (GERN)	United States	$0.977B	0.00
Palvella Therapeutics (PVLA)	United States	$0.973B	0.00
CytomX Therapeutics (CTMX)	United States	$0.961B	14.18
Castle Biosciences (CSTL)	United States	$0.956B	131.00
AbCellera Biologics (ABCL)	Canada	$0.946B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.935B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
Pacira BioSciences (PCRX)	United States	$0.903B	10.35
ArriVent BioPharma (AVBP)	United States	$0.902B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$0.898B	0.00
Arvinas (ARVN)	United States	$0.866B	0.00
Inventiva S.A (IVA)	France	$0.858B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.856B	0.00
DBV Technologies S.A (DBVT)	France	$0.854B	0.00
Bicara Therapeutics (BCAX)	United States	$0.841B	0.00
YD Bio (YDES)		$0.795B	0.00
GH Research (GHRS)	Ireland	$0.789B	0.00
Janux Therapeutics (JANX)	United States	$0.786B	0.00
MapLight Therapeutics (MPLT)	United States	$0.770B	0.00
MiMedx (MDXG)	United States	$0.763B	13.55
Gyre Therapeutics (GYRE)	United States	$0.759B	98.50
Jade Biosciences (JBIO)	United States	$0.756B	0.00
BioAge Labs (BIOA)	United States	$0.743B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.739B	0.00
Arbutus Biopharma (ABUS)	United States	$0.739B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.723B	0.00
Astria Therapeutics (ATXS)	United States	$0.718B	0.00
Annexon (ANNX)	United States	$0.686B	0.00
Kura Oncology (KURA)	United States	$0.681B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Prime Medicine (PRME)	United States	$0.644B	0.00
Replimune (REPL)	United States	$0.640B	0.00
EnGene Holdings (ENGN)	Canada	$0.640B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.612B	0.00
CorMedix Inc (CRMD)	United States	$0.606B	5.61
LB Pharmaceuticals Inc (LBRX)	United States	$0.603B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.598B	0.00
Design Therapeutics (DSGN)	United States	$0.585B	0.00
Emergent Biosolutions (EBS)	United States	$0.574B	5.52
Cytek Biosciences (CTKB)	United States	$0.572B	0.00
Evommune (EVMN)	United States	$0.546B	0.00
Keros Therapeutics (KROS)	United States	$0.535B	11.41
SELLAS Life Sciences (SLS)	United States	$0.531B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.527B	0.00
Gossamer Bio (GOSS)	United States	$0.523B	0.00
REGENXBIO (RGNX)	United States	$0.523B	0.00
Solid Biosciences (SLDB)	United States	$0.508B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.497B	0.00
Prothena (PRTA)	Ireland	$0.480B	0.00
Myriad Genetics (MYGN)	United States	$0.477B	0.00
Alto Neuroscience (ANRO)	United States	$0.473B	0.00
Kamada (KMDA)	Israel	$0.472B	22.81
Tectonic Therapeutic (TECX)	United States	$0.456B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.447B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.447B	0.00
Verastem (VSTM)	United States	$0.445B	0.00
LENZ Therapeutics (LENZ)	United States	$0.445B	0.00
Contineum Therapeutics (CTNM)	United States	$0.438B	0.00
PureTech Health (PRTC)	United States	$0.437B	0.00
NovaBridge Biosciences (NBP)	United States	$0.427B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.424B	0.00
Ocugen (OCGN)	United States	$0.415B	0.00
Benitec Biopharma (BNTC)	United States	$0.415B	0.00
Niagen Bioscience (NAGE)	United States	$0.415B	32.50
Northwest Biotherapeutics (NWBO)	United States	$0.406B	0.00
Absci (ABSI)	United States	$0.405B	0.00
Entrada Therapeutics (TRDA)	United States	$0.405B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.402B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.396B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.393B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.392B	0.00
Zura Bio (ZURA)	United States	$0.391B	0.00
Prima BioMed (IMMP)	Australia	$0.386B	0.00
Monopar Therapeutics (MNPR)	United States	$0.386B	0.00
Allogene Therapeutics (ALLO)	United States	$0.380B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.378B	0.00
Climb Bio (CLYM)	United States	$0.371B	0.00
Invivyd (IVVD)	United States	$0.371B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.369B	0.00
Anavex Life Sciences (AVXL)	United States	$0.366B	0.00
GENFIT S.A (GNFTY)	France	$0.361B	0.00
Immix Biopharma (IMMX)	United States	$0.357B	0.00
Aura Biosciences (AURA)	United States	$0.356B	0.00
Neumora Therapeutics (NMRA)	United States	$0.354B	0.00
Puma Biotechnology (PBYI)	United States	$0.350B	9.38
Kyverna Therapeutics (KYTX)	United States	$0.347B	0.00
Forte Biosciences (FBRX)	United States	$0.346B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.342B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.324B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.324B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.321B	0.00
Candel Therapeutics (CADL)	United States	$0.320B	0.00
Immuneering (IMRX)	United States	$0.318B	0.00
AC Immune (ACIU)	Switzerland	$0.315B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.311B	0.00
PepGen (PEPG)	United States	$0.308B	0.00
XOMA Royalty (XOMA)	United States	$0.308B	0.00
Amarin (AMRN)	Ireland	$0.307B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.300B	0.00
Rezolute (RZLT)	United States	$0.289B	0.00
Lifecore Biomedical (LFCR)	United States	$0.284B	0.00
Abeona Therapeutics (ABEO)	United States	$0.278B	4.54
Aardvark Therapeutics (AARD)	United States	$0.275B	0.00
Adherex Technologies (FENC)	United States	$0.268B	0.00
Neurogene (NGNE)	United States	$0.267B	0.00
Coherus Oncology (CHRS)	United States	$0.259B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.256B	0.00
Palisade Bio (PALI)	United States	$0.244B	0.00
Cabaletta Bio (CABA)	United States	$0.242B	0.00
Shattuck Labs (STTK)	United States	$0.239B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Nuvectis Pharma (NVCT)	United States	$0.228B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.221B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.215B	0.00
Alector (ALEC)	United States	$0.214B	0.00
Opus Genetics (IRD)	United States	$0.208B	0.00
Voyager Therapeutics (VYGR)	United States	$0.205B	0.00
SAB Biotherapeutics (SABS)	United States	$0.199B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.190B	0.00
Sagimet Biosciences (SGMT)	United States	$0.180B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.180B	0.00
Editas Medicine (EDIT)	United States	$0.178B	0.00
C4 Therapeutics (CCCC)	United States	$0.176B	0.00
Humacyte (HUMA)	United States	$0.176B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.173B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.173B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.169B	0.00
Innate Pharma S.A (IPHA)	France	$0.160B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.158B	0.00
Tharimmune (THAR)	United States	$0.156B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.156B	0.00
Alps Group (ALPS)	United States	$0.155B	2.82
Anika Therapeutics (ANIK)	United States	$0.151B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.150B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.148B	0.00
Caribou Biosciences (CRBU)	United States	$0.147B	0.00
Elicio Therapeutics (ELTX)	United States	$0.146B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.145B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Nkarta (NKTX)	United States	$0.143B	0.00
Jyong Biotech (MENS)	Taiwan	$0.142B	0.00
Vor Biopharma (VOR)		$0.137B	0.00
Spero Therapeutics (SPRO)	United States	$0.136B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.136B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.135B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.135B	0.00
Sutro Biopharma (STRO)	United States	$0.132B	0.00
Crescent Biopharma (CBIO)	United States	$0.132B	0.00
Fate Therapeutics (FATE)	United States	$0.132B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.131B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.130B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.128B	6.26
Seres Therapeutics (MCRB)	United States	$0.126B	0.00
Adagene (ADAG)	China	$0.124B	0.00
Alpha Teknova (TKNO)	United States	$0.120B	0.00
Codexis (CDXS)	United States	$0.120B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.118B	0.00
VTv Therapeutics (VTVT)	United States	$0.114B	0.00
Repare Therapeutics (RPTX)	Canada	$0.114B	0.00
Ovid Therapeutics (OVID)	United States	$0.114B	0.00
Turn Therapeutics (TTRX)	United States	$0.113B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.111B	0.00
Alpha Cognition (ACOG)	Canada	$0.111B	0.00
BGM Group (BGM)	China	$0.111B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.111B	0.00
Cardiff Oncology (CRDF)	United States	$0.108B	0.00
BioStem Technologies (BSEM)		$0.105B	7.34
Actuate Therapeutics (ACTU)	United States	$0.103B	0.00
Fortress Biotech (FBIO)	United States	$0.101B	0.00
Coya Therapeutics (COYA)	United States	$0.101B	0.00
Agenus (AGEN)	United States	$0.100B	0.00
Seer (SEER)	United States	$0.100B	0.00
Citius Oncology (CTOR)	United States	$0.100B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.099B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.099B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.094B	0.00
Cognition Therapeutics (CGTX)	United States	$0.094B	0.00
Equillium (EQ)	United States	$0.093B	0.00
Genelux (GNLX)	United States	$0.091B	0.00
EXoZymes (EXOZ)	United States	$0.088B	0.00
ATyr Pharma (ATYR)	United States	$0.088B	0.00
Precision BioSciences (DTIL)	United States	$0.087B	0.00
Biomea Fusion (BMEA)	United States	$0.086B	0.00
MaxCyte (MXCT)	United States	$0.086B	0.00
Tenax Therapeutics (TENX)	United States	$0.079B	0.00
IBio (IBIO)	United States	$0.079B	0.00
BioHarvest Sciences (BHST)	Canada	$0.079B	0.00
MediciNova (MNOV)	United States	$0.079B	0.00
Spruce Biosciences (SPRB)	United States	$0.078B	0.00
ImageneBio (IMA)	United States	$0.077B	0.00
Immunic (IMUX)	United States	$0.075B	0.00
XBiotech (XBIT)	United States	$0.072B	0.00
OKYO Pharma (OKYO)		$0.072B	0.00
Scilex Holding (SCLX)	United States	$0.072B	0.00
Pliant Therapeutics (PLRX)	United States	$0.070B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.068B	0.00
Adicet Bio (ACET)	United States	$0.067B	0.00
Annovis Bio (ANVS)	United States	$0.066B	0.00
BeyondSpring (BYSI)	United States	$0.061B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.060B	0.00
InflaRx (IFRX)	Germany	$0.060B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.059B	0.00
TScan Therapeutics (TCRX)	United States	$0.058B	0.00
Cingulate (CING)	United States	$0.057B	0.00
Grace Therapeutics (GRCE)	United States	$0.056B	0.00
Estrella Immunopharma (ESLA)	United States	$0.055B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.055B	0.00
Instil Bio (TIL)	United States	$0.053B	0.00
Q32 Bio (QTTB)	United States	$0.052B	0.00
MiNK Therapeutics (INKT)	United States	$0.051B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.050B	0.00
CervoMed (CRVO)	United States	$0.049B	0.00
Entera Bio (ENTX)	Israel	$0.048B	0.00
Clene (CLNN)	United States	$0.047B	0.00
Aligos Therapeutics (ALGS)	United States	$0.045B	0.00
Kezar Life Sciences (KZR)	United States	$0.045B	0.00
ABVC BioPharma (ABVC)	United States	$0.044B	0.00
Elutia (ELUT)	United States	$0.042B	0.00
Galecto (GLTO)	Denmark	$0.040B	0.00
INmune Bio (INMB)	United States	$0.040B	0.00
Lisata Therapeutics (LSTA)	United States	$0.040B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.040B	0.00
NextCure (NXTC)	United States	$0.039B	0.00
TuHURA Biosciences (HURA)	United States	$0.038B	0.00
Jasper Therapeutics (JSPR)	United States	$0.038B	0.00
Celularity (CELU)	United States	$0.037B	0.00
Xilio Therapeutics (XLO)	United States	$0.037B	0.00
RenovoRx (RNXT)	United States	$0.036B	0.00
Generation Bio (GBIO)	United States	$0.036B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.035B	2.24
PDS Biotechnology (PDSB)	United States	$0.035B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.035B	0.00
Pluri (PLUR)	Israel	$0.035B	0.00
OnKure Therapeutics (OKUR)	United States	$0.034B	0.00
Hyperion DeFi (HYPD)	United States	$0.034B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.033B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.033B	0.00
TELA Bio (TELA)	United States	$0.033B	0.00
Oncobiologics (OTLK)	United States	$0.032B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Dyadic (DYAI)	United States	$0.031B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.030B	0.00
Passage Bio (PASG)	United States	$0.030B	0.00
Rein Therapeutics (RNTX)	United States	$0.030B	0.00
AN2 Therapeutics (ANTX)	United States	$0.030B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.030B	0.00
Femasys (FEMY)	United States	$0.030B	0.00
Lantern Pharma (LTRN)	United States	$0.030B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.029B	0.00
Medicus Pharma (MDCX)	United States	$0.028B	0.00
Promis Neurosciences (PMN)	Canada	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
Skye Bioscience (SKYE)	United States	$0.026B	0.00
Boundless Bio (BOLD)	United States	$0.026B	0.00
Exicure (XCUR)	United States	$0.026B	0.00
Aytu BioPharma (AYTU)	United States	$0.026B	0.00
Cue Biopharma (CUE)	United States	$0.025B	0.00
IO Biotech (IOBT)	Denmark	$0.025B	0.00
Rallybio (RLYB)	United States	$0.025B	0.00
Senti Biosciences (SNTI)	United States	$0.024B	0.00
Dare Bioscience (DARE)	United States	$0.024B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.022B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
Apollomics (APLM)	United States	$0.021B	0.00
Intensity Therapeutics (INTS)	United States	$0.021B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.021B	0.00
IN8bio (INAB)	United States	$0.019B	0.00
LeonaBio (LONA)	United States	$0.018B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.018B	0.00
FibroBiologics (FBLG)	United States	$0.017B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.017B	0.00
Black Titan (BTTC)	United States	$0.016B	0.00
Quantum Biopharma (QNTM)	Canada	$0.016B	0.00
Applied Therapeutics (APLT)	United States	$0.014B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.014B	0.00
Polyrizon (PLRZ)	Israel	$0.013B	0.00
BioAtla (BCAB)	United States	$0.013B	0.00
Cocrystal Pharma (COCP)	United States	$0.013B	0.00
Allarity Therapeutics (ALLR)	United States	$0.013B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.013B	0.00
Curis (CRIS)	United States	$0.013B	0.00
BioCardia (BCDA)	United States	$0.013B	0.00
NewcelX (NCEL)	Switzerland	$0.013B	0.00
Hoth Therapeutics (HOTH)	United States	$0.013B	0.00
Bionano Genomics (BNGO)	United States	$0.012B	0.00
Soligenix (SNGX)	United States	$0.011B	0.00
Revelation Biosciences (REVB)	United States	$0.011B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.011B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.011B	0.00
Longeveron (LGVN)	United States	$0.011B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.011B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.010B	0.00
Imunon (IMNN)	United States	$0.010B	0.00
Novogen (KZIA)	Australia	$0.010B	0.00
Biofrontera (BFRI)	United States	$0.010B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.009B	0.00
Edesa Biotech (EDSA)	Canada	$0.009B	0.00
Biorestorative Therapies (BRTX)	United States	$0.009B	0.00
Beyond Air (XAIR)	United States	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.009B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.009B	0.00
CalciMedica (CALC)	United States	$0.009B	0.00
Mainz Biomed (MYNZ)	Germany	$0.009B	0.00
Quince Therapeutics (QNCX)	United States	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.008B	0.00
Gelteq (GELS)	Australia	$0.008B	0.00
Alzamend Neuro (ALZN)	United States	$0.008B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
GENPREX (GNPX)	United States	$0.007B	0.00
Aptevo Therapeutics (APVO)	United States	$0.007B	0.00
IMMURON (IMRN)	Australia	$0.007B	0.00
VivoSim Labs (VIVS)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
Evogene (EVGN)	Israel	$0.006B	0.00
Mustang Bio (MBIO)	United States	$0.006B	0.00
GT Biopharma (GTBP)	United States	$0.006B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.006B	0.00
Dermata Therapeutics (DRMA)	United States	$0.005B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.005B	0.00
Advanced Biomed (ADVB)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
Aprea Therapeutics (APRE)	United States	$0.005B	0.00
GeoVax Labs (GOVX)	United States	$0.005B	0.00
KALA BIO (KALA)	United States	$0.004B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.004B	0.00
Abpro Holdings (ABP)	United States	$0.004B	0.00
Silo Pharma (SILO)	United States	$0.004B	0.00
MetaVia (MTVA)	United States	$0.004B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.004B	0.00
BioAffinity Technologies (BIAF)	United States	$0.004B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.003B	0.00
GRI Bio (GRI)	United States	$0.003B	0.00
HCW Biologics (HCWB)	United States	$0.003B	0.00
Psyence Biomedical (PBM)	Canada	$0.003B	0.00
AquaBounty Technologies (AQB)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.003B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.003B	0.00
Avalon GloboCare (ALBT)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.003B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.002B	0.00
Onconetix (ONCO)	United States	$0.002B	0.00
Ensysce Biosciences (ENSC)	United States	$0.002B	0.00
Enveric Biosciences (ENVB)	United States	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Compugen (CGEN)	Israel	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pharvaris (PHVS)	Netherlands	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00